Clovis Oncology Inc (CLVS)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

5500 FLATIRON PARKWAY BOULDER, CO 80301

Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets. Clovis Oncology targets development programs at specific subsets of cancer populations, and simultaneously develops, with partners, for those indications that require them, diagnostic tools intended to direct a compound in development to the population that is most likely to benefit from its use. Clovis Oncology is headquartered in Boulder, Colorado, with additional office locations in the U.S. and Europe.

Data as of 2021-10-17 09:39:49 -0400
Market Cap513.898 Million Shares Outstanding118.41 Million Avg 30-day Volume2.171 Million
P/E Ratio-1.65582 Dividend Yield EPS-3.12
Price/Sales3.27 Debt to Equity-2.76 EBITDA-245.546 Million
Price to Book Value-2.48 Forward PE-1.95 Enterprise Value931.171 Million
Total Cash230.204 Million Current Debt173.879 Million Gross Profit122.47 Million
BETA1.12296 52-week High/Low11.1 / 4.06 Next Earnings Date2021-11-04 Price to Cash FLow (P/CF) -7.2546
Data provided by IEX Cloud
View SEC Filings from CLVS instead.

View recent insider trading info

Funds Holding CLVS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CLVS BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

1.3 Thousand total shares from 7 transactions

Exercise Derivative Conversion (M)

2.8 Thousand total shares from 7 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

HARDING THOMAS C. SEE REMARKS

  • Officer
6,565 2021-10-01 14

IVERS-READ GILLIAN C SEE REMARKS

  • Officer
511,639 2021-09-01 10

MUEHL DANIEL W SEE REMARKS

  • Officer
124,102 2021-09-01 8

ROLFE LINDSEY SEE REMARKS

  • Officer
157,966 2021-09-01 10

GROSS PAUL EDWARD SEE REMARKS

  • Officer
112,010 2021-09-01 8

SIMANTOV RONIT

  • Director
0 2021-07-12 2

KLINGENSTEIN PAUL H

  • Director
42,223 2021-06-10 1

BLAIR JAMES C

  • Director
42,223 2021-06-10 1

GRAHAM GINGER L

  • Director
42,223 2021-06-10 1

ATWOOD BRIAN G

  • Director
42,223 2021-06-10 2

SPICKSCHEN THORLEF

  • Director
42,223 2021-06-10 1

MCKINLEY EDWARD J

  • Director
42,223 2021-06-10 1

FLAHERTY KEITH T.

  • Director
42,223 2021-06-10 1

AZELBY ROBERT

  • Director
42,223 2021-06-10 1

FAIR RICHARD A.

  • Director
42,223 2021-06-10 1

MAHAFFY PATRICK J SEE REMARKS

  • Officer
  • Director
380,000 2021-03-01 1

BARRETT M JAMES

  • Director
0 2018-10-11 0

FAIR RICHARD A.

FAIR RICHARD A.

  • Director
0 2018-10-11 1

HOOKS CORWIN DALE SEE REMARKS

  • Officer
5,349 2018-09-05 0

MAST ERLE T EXECUTIVE VP AND CFO

  • Officer
135,583 2015-11-02 0

HOERTER STEVEN L. SEE REMARKS

  • Officer
0 2015-03-05 0

ALLEN ANDREW R SEE REMARKS

  • Officer
0 2015-03-02 0

DP VII ASSOCIATES LP

BLAIR JAMES C

DOVEY BRIAN H

TREU JESSE I

VITULLO NICOLE

HALAK BRIAN K

SCHOEMAKER KATHLEEN K

  • Director
  • 10% Owner
44,034 2013-06-04 0

DOMAIN PARTERS VII L P

BLAIR JAMES C

DOVEY BRIAN H

TREU JESSE I

VITULLO NICOLE

HALAK BRIAN K

SCHOEMAKER KATHLEEN K

  • Director
  • 10% Owner
2,581,745 2013-06-04 0

BARRIS PETER J

  • 10% Owner
No longer subject to file 2013-06-03 0

MOTT DAVID M

  • 10% Owner
No longer subject to file 2013-06-03 0

KERINS PATRICK J

  • 10% Owner
No longer subject to file 2013-06-03 0

SANDELL SCOTT D

  • 10% Owner
No longer subject to file 2013-06-03 0

KOLLURI KRISHNA KITTU

  • 10% Owner
No longer subject to file 2013-06-03 0

BASKETT FOREST

  • 10% Owner
No longer subject to file 2013-06-03 0

DRANT RYAN D

  • 10% Owner
No longer subject to file 2013-06-03 0

WELLER HARRY R

  • 10% Owner
No longer subject to file 2013-06-03 0

NEW ENTERPRISE ASSOCIATES 13 LP

  • 10% Owner
No longer subject to file 2013-06-03 0

VERSANT VENTURE CAPITAL IV, L.P.

VERSANT SIDE FUND IV, L.P.

VERSANT VENTURES IV, LLC

  • 10% Owner
No longer subject to file 2013-06-03 0

NEA PARTNERS 13, LIMITED PARTNERSHIP

NEA 13 GP, LTD

  • 10% Owner
No longer subject to file 2013-06-03 0

VISWANATHAN RAVI

  • 10% Owner
No longer subject to file 2013-06-03 0

REED JOHN C

  • Director
0 2012-06-14 0

KRAMLICH C RICHARD

  • 10% Owner
3,419,671 2011-11-21 0

TREU JESSE I

  • 10% Owner
3,041,950 2011-11-21 0

VITULLO NICOLE

  • 10% Owner
3,041,950 2011-11-21 0

DOVEY BRIAN H

  • 10% Owner
3,041,950 2011-11-21 0

SCHOEMAKER KATHLEEN K

  • 10% Owner
3,041,950 2011-11-21 0

HALAK BRIAN K

  • 10% Owner
3,041,950 2011-11-21 0

DP VII ASSOCIATES LP

  • 10% Owner
51,013 2011-11-21 0

DOMAIN PARTERS VII L P

  • 10% Owner
2,990,937 2011-11-21 0

NEW ENTERPRISE ASSOCIATES 13 LP

NEA 13 GP, LTD

NEA PARTNERS 13, LIMITED PARTNERSHIP

  • 10% Owner
3,419,671 2011-11-21 0

DOMAIN ASSOCIATES

  • 10% Owner
32,758 2011-11-15 0

KAMDAR KIM P.

  • 10% Owner
32,758 2011-11-15 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

HARDING THOMAS C. - Officer SEE REMARKS by wife

2021-10-05 16:31:05 -0400 2021-10-04 S 6 $4.41 d 1,412 indirect 1.8519 3.2407 3.2407 6 -0.2315 4

HARDING THOMAS C. - Officer SEE REMARKS by wife

2021-10-05 16:31:05 -0400 2021-10-01 M 15 d 172 indirect

HARDING THOMAS C. - Officer SEE REMARKS by wife

2021-10-05 16:31:05 -0400 2021-10-01 M 15 a 1,418 indirect 1.8519 3.2407 3.2407 6 -0.2315 4

IVERS-READ GILLIAN C - Officer SEE REMARKS

2021-09-03 16:15:53 -0400 2021-09-02 S 304 $4.89 d 254,980 direct -4.9569 -7.7586 -6.25 4.9569 15 -9.6983 30

HARDING THOMAS C. - Officer SEE REMARKS

2021-09-03 17:21:00 -0400 2021-09-02 S 141 $4.89 d 3,563 direct -4.9569 -7.7586 -6.25 4.9569 15 -9.6983 30

ROLFE LINDSEY - Officer SEE REMARKS

2021-09-03 16:15:17 -0400 2021-09-02 S 347 $4.89 d 78,122 direct -4.9569 -7.7586 -6.25 4.9569 15 -9.6983 30

MUEHL DANIEL W - Officer SEE REMARKS

2021-09-03 16:16:13 -0400 2021-09-02 S 249 $4.89 d 61,364 direct -4.9569 -7.7586 -6.25 4.9569 15 -9.6983 30

GROSS PAUL EDWARD - Officer SEE REMARKS

2021-09-03 16:15:36 -0400 2021-09-02 S 249 $4.89 d 55,318 direct -4.9569 -7.7586 -6.25 4.9569 15 -9.6983 30

HARDING THOMAS C. - Officer SEE REMARKS by wife

2021-09-03 17:21:00 -0400 2021-09-02 S 7 $4.89 d 1,403 indirect -4.9569 -7.7586 -6.25 4.9569 15 -9.6983 30

GROSS PAUL EDWARD - Officer SEE REMARKS

2021-09-03 16:15:36 -0400 2021-09-01 M 563 a 55,567 direct -4.9569 -7.7586 -6.25 4.9569 15 -9.6983 30

IVERS-READ GILLIAN C - Officer SEE REMARKS

2021-09-03 16:15:53 -0400 2021-09-01 M 688 d 1,375 direct

HARDING THOMAS C. - Officer SEE REMARKS by wife

2021-09-03 17:21:00 -0400 2021-09-01 M 19 d 37 indirect

HARDING THOMAS C. - Officer SEE REMARKS by wife

2021-09-03 17:21:00 -0400 2021-09-01 M 19 a 1,410 indirect -4.9569 -7.7586 -6.25 4.9569 15 -9.6983 30

ROLFE LINDSEY - Officer SEE REMARKS

2021-09-03 16:15:17 -0400 2021-09-01 M 688 d 1,375 direct

MUEHL DANIEL W - Officer SEE REMARKS

2021-09-03 16:16:13 -0400 2021-09-01 M 563 d 1,125 direct

GROSS PAUL EDWARD - Officer SEE REMARKS

2021-09-03 16:15:36 -0400 2021-09-01 M 563 d 1,125 direct

HARDING THOMAS C. - Officer SEE REMARKS

2021-09-03 17:21:00 -0400 2021-09-01 M 281 d 563 direct

IVERS-READ GILLIAN C - Officer SEE REMARKS

2021-09-03 16:15:53 -0400 2021-09-01 M 688 a 255,284 direct -4.9569 -7.7586 -6.25 4.9569 15 -9.6983 30

HARDING THOMAS C. - Officer SEE REMARKS

2021-09-03 17:21:00 -0400 2021-09-01 M 281 a 3,704 direct -4.9569 -7.7586 -6.25 4.9569 15 -9.6983 30

ROLFE LINDSEY - Officer SEE REMARKS

2021-09-03 16:15:17 -0400 2021-09-01 M 688 a 78,469 direct -4.9569 -7.7586 -6.25 4.9569 15 -9.6983 30

MUEHL DANIEL W - Officer SEE REMARKS

2021-09-03 16:16:13 -0400 2021-09-01 M 563 a 61,613 direct -4.9569 -7.7586 -6.25 4.9569 15 -9.6983 30

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
CLOVIS ONCOLOGY INC CLVS 2021-10-21 22:15:02 UTC -0.8175 0.8875 350000
CLOVIS ONCOLOGY INC CLVS 2021-10-21 21:45:03 UTC -0.8172 0.8872 350000
CLOVIS ONCOLOGY INC CLVS 2021-10-21 21:15:04 UTC -0.8172 0.8872 350000
CLOVIS ONCOLOGY INC CLVS 2021-10-21 20:45:03 UTC -0.8148 0.8848 350000
CLOVIS ONCOLOGY INC CLVS 2021-10-21 20:15:03 UTC -0.8148 0.8848 350000
CLOVIS ONCOLOGY INC CLVS 2021-10-21 19:45:03 UTC -0.8148 0.8848 350000
CLOVIS ONCOLOGY INC CLVS 2021-10-21 19:15:02 UTC -0.8148 0.8848 350000
CLOVIS ONCOLOGY INC CLVS 2021-10-21 18:45:03 UTC -0.8528 0.9228 350000
CLOVIS ONCOLOGY INC CLVS 2021-10-21 18:15:03 UTC -0.8528 0.9228 350000
CLOVIS ONCOLOGY INC CLVS 2021-10-21 17:45:03 UTC -0.8528 0.9228 350000
CLOVIS ONCOLOGY INC CLVS 2021-10-21 17:15:03 UTC -0.8528 0.9228 350000
CLOVIS ONCOLOGY INC CLVS 2021-10-21 16:45:03 UTC -0.85 0.92 350000
CLOVIS ONCOLOGY INC CLVS 2021-10-21 16:15:03 UTC -0.85 0.92 350000
CLOVIS ONCOLOGY INC CLVS 2021-10-21 15:45:03 UTC -0.85 0.92 400000
CLOVIS ONCOLOGY INC CLVS 2021-10-21 15:15:03 UTC -0.85 0.92 400000
CLOVIS ONCOLOGY INC CLVS 2021-10-21 14:45:03 UTC -0.818 0.888 400000
CLOVIS ONCOLOGY INC CLVS 2021-10-21 14:15:03 UTC -0.818 0.888 400000
CLOVIS ONCOLOGY INC CLVS 2021-10-21 13:45:03 UTC -0.818 0.888 400000
CLOVIS ONCOLOGY INC CLVS 2021-10-21 13:15:02 UTC -0.818 0.888 350000
CLOVIS ONCOLOGY INC CLVS 2021-10-21 12:45:03 UTC -0.818 0.888 300000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
AQR Funds- AQR Multi-Strategy Alternative Fund CLVS -4996.0 shares, $-29126.68 2020-09-30 N-PORT
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund CLVS -32200.0 shares, $-186760.0 2021-06-30 N-PORT

Elevate your investments